We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
(+7.6%)
Cap. Flow
+$567M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.7M |
| 2 |
PepsiCo
PEP
|
+$76.8M |
| 3 |
Marriott International
MAR
|
+$64.8M |
| 4 |
Tyson Foods
TSN
|
+$62.8M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$64.8M |
| 2 |
Hormel Foods
HRL
|
+$61.4M |
| 3 |
Gilead Sciences
GILD
|
+$59.9M |
| 4 |
Hilton Worldwide
HLT
|
+$54.7M |
| 5 |
TechnipFMC
FTI
|
+$51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.71% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHPG
401
DELISTED
Shire pic
SHPG
| $6.11M | 0.03% |
31,507
-22,103
| -41% | -$4.31M |
|
402
Range Resources
RRC
$9.11B
| $6.03M | 0.03% |
155,747
+150,897
| +3,111% | +$6.1M |
|
403
Zimmer Biomet
ZBH
$17.7B
| $5.99M | 0.03% |
47,486
-448
| -0.9% | -$55.4K |
|
404
Invesco QQQ Trust
QQQ
$455B
| $5.98M | 0.03% |
50,386
-309
| -0.6% | -$35.7K |
|
|
MRO
405
DELISTED
Marathon Oil Corporation
MRO
| $5.92M | 0.03% |
374,655
-57,416
| -13% | -$852K |
|
406
Aflac
AFL
$63.9B
| $5.92M | 0.03% |
164,766
-1,748
| -1% | -$63.6K |
|
407
Mitsubishi UFJ Financial
MUFG
$258B
| $5.83M | 0.03% |
1,154,187
+34,760
| +3% | +$175K |
|
408
Vanguard Real Estate ETF
VNQ
$39.9B
| $5.79M | 0.03% |
66,816
-992
| -1% | -$88.5K |
|
|
WRI
409
DELISTED
Weingarten Realty Investors
WRI
| $5.72M | 0.03% |
146,738
+606
| +0.4% | +$25K |
|
410
Prudential
PUK
$36.5B
| $5.71M | 0.03% |
165,026
+4,757
| +3% | +$164K |
|
|
MON
411
DELISTED
Monsanto Co
MON
| $5.69M | 0.03% |
55,663
-4,609
| -8% | -$484K |
|
412
Plains All American Pipeline
PAA
$17.4B
| $5.67M | 0.03% |
180,639
-56,060
| -24% | -$1.6M |
|
413
Microchip Technology
MCHP
$42.8B
| $5.67M | 0.03% |
182,600
-1,530
| -0.8% | -$44.5K |
|
414
Energy Transfer Partners
ET
$70.1B
| $5.66M | 0.03% |
337,217
-3,550
| -1% | -$59.9K |
|
415
International Flavors & Fragrances
IFF
$19.4B
| $5.59M | 0.03% |
39,128
+4,927
| +14% | +$667K |
|
416
Fortive
FTV
$19B
| $5.52M | 0.03% |
+172,073
| New | +$5.52M |
|
417
J.M. Smucker
SJM
$12.6B
| $5.45M | 0.03% |
40,227
+9,904
| +33% | +$1.45M |
|
418
Sumitomo Mitsui Financial
SMFG
$166B
| $5.35M | 0.03% |
792,640
-9,743
| -1% | -$63.2K |
|
419
iShares Russell 1000 Value ETF
IWD
$82B
| $5.33M | 0.03% |
50,429
-118
| -0.2% | -$12.4K |
|
420
iShares Russell 1000 ETF
IWB
$47.7B
| $5.28M | 0.03% |
43,857
+1,617
| +4% | +$194K |
|
421
iShares MSCI Emerging Markets ETF
EEM
$28B
| $5.27M | 0.03% |
140,752
+12,880
| +10% | +$471K |
|
|
WCG
422
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.07M | 0.03% |
43,305
+12,997
| +43% | +$1.45M |
|
423
HP
HPQ
$23.5B
| $5.02M | 0.03% |
323,663
+5,817
| +2% | +$82.9K |
|
424
Cigna
CI
$76.6B
| $5M | 0.03% |
38,411
-1,806
| -4% | -$236K |
|
425
Gentex
GNTX
$4.88B
| $4.99M | 0.03% |
284,485
-171,736
| -38% | -$2.97M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.
- Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
- Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
- Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
- Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
- Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
- Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
- Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.
Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.